Alfonso Calvo

21PUBLICATIONS
121CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Surface water quality processes and contaminated sediment assessmentOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 15, 2026
CXCL9-driven immune rewiring and tumor-intrinsic ATR signaling inhibition restore radiotherapy response in lung cancer.

|May 27, 2026
Loss of PTEN as an Independent Poor Prognosis Indicator in Lung Adenocarcinoma, but Not in Squamous Cell Carcinoma, Is Associated with an Immunosuppressive Tumor Microenvironment and Distinct Co-Mutational Profiles.

|Aug 14, 2025
Evaluation of nanoencapsulated bevacizumab combined with paclitaxel in a colorectal cancer xenograft model.

Cristina Pangua, Socorro Espuelas, Jon Ander Simón

|Jul 25, 2025
Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy.

Esther Redin, Nerea Otegui, Mirentxu Santos

|Nov 09, 2024
The Evidence Base for Circulating Tumor DNA-Methylation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Debora Maffeo, Angela Rina, Viola Bianca Serio

|Oct 25, 2024
Enhancing bevacizumab efficacy in a colorectal tumor mice model using dextran-coated albumin nanoparticles.

Cristina Pangua, Socorro Espuelas, Jon Ander Simón

Pageof 4

Frequent Collaborators

8 joint publications

Luis Montuenga

6 joint publications

Diego Serrano

5 joint publications

Francisco Exposito

5 joint publications

Esther Redin